4-甲基-3-硝基苯甲酰氯结构式
|
常用名 | 4-甲基-3-硝基苯甲酰氯 | 英文名 | 4-Methyl-3-nitrobenzoyl chloride |
---|---|---|---|---|
CAS号 | 10397-30-5 | 分子量 | 199.59100 | |
密度 | 1.37 g/mL at 25 °C(lit.) | 沸点 | 185 °C36 mm Hg(lit.) | |
分子式 | C8H6ClNO3 | 熔点 | 20-21 °C(lit.) | |
MSDS | 中文版 美版 | 闪点 | >230 °F | |
符号 |
GHS05 |
信号词 | Danger |
中文名 | 4-甲基-3-硝基苯甲酰氯 |
---|---|
英文名 | 4-Methyl-3-nitrobenzoyl chloride |
中文别名 | 3-硝基-4-甲基苯甲酰氯 | 4-硝基-3-甲基苯甲酰氯 |
英文别名 | 更多 |
密度 | 1.37 g/mL at 25 °C(lit.) |
---|---|
沸点 | 185 °C36 mm Hg(lit.) |
熔点 | 20-21 °C(lit.) |
分子式 | C8H6ClNO3 |
分子量 | 199.59100 |
闪点 | >230 °F |
精确质量 | 199.00400 |
PSA | 62.89000 |
LogP | 2.80540 |
外观性状 | 黄色液体或油状 |
蒸汽压 | 0.0012mmHg at 25°C |
折射率 | n20/D 1.581(lit.) |
储存条件 | 室温 |
分子结构 | 1、摩尔折射率:47.86 2、摩尔体积(cm3/mol):143.9 3、等张比容(90.2K):384.2 4、表面张力(dyne/cm):50.7 5、介电常数:无可用的 6、极化率(10-24cm3):18.97 7、单一同位素质量:199.003621 Da 8、标称质量:199 Da 9、平均质量:199.5911 Da |
计算化学 | 1.疏水参数计算参考值(XlogP):无 2.氢键供体数量:0 3.氢键受体数量:3 4.可旋转化学键数量:1 5.互变异构体数量:3 6.拓扑分子极性表面积62.9 7.重原子数量:13 8.表面电荷:0 9.复杂度:226 10.同位素原子数量:0 11.确定原子立构中心数量:0 12.不确定原子立构中心数量:0 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:1 |
更多 | 1. 性状:液体 2. 密度(g/mLat 25°C):1.37 3. 相对蒸汽密度(g/mL,空气=1):未确定 4. 熔点(ºC):20-21 5. 沸点(ºC,常压):未确定 6. 沸点(ºC,36mmHg):185 7. 折射率(n20/D):1.581 8. 闪点(ºC):113 9. 比旋光度(º):未确定 10. 自燃点或引燃温度(ºC):未确定 11. 蒸气压(mmHg,37ºC):未确定 12. 饱和蒸气压(kPa,114.4 ºC):未确定 13. 燃烧热(KJ/mol):未确定 14. 临界温度(ºC):未确定 15. 临界压力(MPa):未确定 16. 油水(辛醇/水)分配系数的对数值:未确定 17. 爆炸上限(%,V/V):未确定 18. 爆炸下限(%,V/V):未确定 19. 溶解性:未确定 |
符号 |
GHS05 |
---|---|
信号词 | Danger |
危害声明 | H314 |
警示性声明 | P280-P305 + P351 + P338-P310 |
个人防护装备 | Faceshields;full-face respirator (US);Gloves;Goggles;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter |
危害码 (欧洲) | C:Corrosive; |
风险声明 (欧洲) | R34 |
安全声明 (欧洲) | S26-S27-S36/37/39-S45 |
危险品运输编码 | UN 3265 8/PG 2 |
WGK德国 | 3 |
海关编码 | 2916399090 |
~98% 4-甲基-3-硝基苯甲酰氯 10397-30-5 |
文献:Li, Shuxin; Yao, Zhenglin; Zhao, Yanjin; Chen, Wei; Wang, Huijia; Kuang, Xianzhao; Zhan, Wenhu; Yao, Shan; Yu, Shanyou; Hu, Wenxiang Bioorganic and Medicinal Chemistry Letters, 2012 , vol. 22, # 16 p. 5279 - 5282 |
~% 4-甲基-3-硝基苯甲酰氯 10397-30-5 |
文献:Journal of the American Chemical Society, , vol. 47, p. 1394 |
~% 4-甲基-3-硝基苯甲酰氯 10397-30-5 |
文献:Journal of the American Chemical Society, , vol. 47, p. 1394 |
~% 4-甲基-3-硝基苯甲酰氯 10397-30-5 |
文献:Journal of the Chemical Society, , vol. 127, p. 2649 |
4-甲基-3-硝基苯甲酰氯上游产品 4 | |
---|---|
4-甲基-3-硝基苯甲酰氯下游产品 10 | |
海关编码 | 2916399090 |
---|---|
中文概述 | 2916399090 其他芳香一元羧酸. 增值税率:17.0% 退税率:9.0% 监管条件:无 最惠国关税:6.5% 普通关税:30.0% |
申报要素 | 品名, 成分含量, 用途, 丙烯酸、丙烯酸盐或酯应报明包装 |
Summary | 2916399090 other aromatic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their derivatives VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0% |
New low-density lipoprotein receptor upregulators acting via a novel mechanism.
J. Med. Chem. 39(17) , 3343-56, (1996) The synthesis and biological activity of a new series of benzamides and related compounds that upregulate the expression of the low-density lipoprotein (LDL) receptor in human hepatocytes (HepG2 cells... |
|
Structural bases of norovirus RNA dependent RNA polymerase inhibition by novel suramin-related compounds.
PLoS ONE 9(3) , e91765, (2014) Noroviruses (NV) are +ssRNA viruses responsible for severe gastroenteritis; no effective vaccines/antivirals are currently available. We previously identified Suramin (9) as a potent inhibitor of NV-R... |
|
Design, synthesis and biological evaluation of novel acrylamide analogues as inhibitors of BCR-ABL kinase.
Bioorg. Med. Chem. Lett. 22(16) , 5279-82, (2012) A series of acrylamide analogues were designed and synthesized from Imatinib and Nilotinib as novel BCR-ABL inhibitors by application of the principle of nonclassical electronic isostere. All new comp... |
MFCD00035747 |
EINECS 233-858-1 |
4-methyl-3-nitro-benzoyl chloride |
4-Methyl-3-nitro-benzoylchlorid |
3-nitro-4-methylbenzoyl chloride |
3-Nitro-p-toluyl chloride |
3-Nitro-p-toluoyl chloride |